Invitae Cataracts Panel
Use
The Invitae Cataracts Panel analyzes genes associated with cataracts, offering a comprehensive evaluation for inherited cataracts. The panel targets a range of genes based on current evidence, which aids in diagnosing and guiding treatment for inherited cataracts. Genetic testing results facilitate recurrence-risk assessment and genetic counseling, although some genes may relate to additional conditions not covered by this test.
Special Instructions
The test utilizes a broad panel approach to assess multiple potential genes responsible for cataracts based on one clinical indication. It is important to refer to any limitations noted in the report.
Limitations
This test may not detect structural rearrangements, complex sequences, or sequence changes in non-coding regions unless specified. Sequence analysis may have reduced sensitivity for larger insertions and deletions, and rare cases may encounter single-exon copy number analysis issues. The report clarifies covered and excluded variant types and regions.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
10-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
3mL
Minimum Volume
Not provided
Container
purple-top EDTA tube (K2EDTA or K3EDTA)